Skip to main content

. 1964 Jun 13;1(5397):1553–1554. doi: 10.1136/bmj.1.5397.1553

Trial of Nifenazone (“Thylin”)

F Dudley Hart, P L Boardman

PMCID: PMC1814611 PMID: 14133613

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CURRIE J. P. Treatment of rheumatoid arthritis with butazolidine . Lancet. 1952 Jul 5;2(6723):15–16. doi: 10.1016/s0140-6736(52)91642-5. [DOI] [PubMed] [Google Scholar]
DZIUBA K. [Treatment of rheumatic diseases and degenerative joint diseases with 4-(N-nicotinoylaminoacetylamino)-1-phenyl-2,3-dimethyl-pyrazolone-(5) HCl]. Arzneimittelforschung. 1961 Nov;11:1049–1051. [PubMed] [Google Scholar]
HARTERT I. [Practical experiences with 4-nicotinamido-2,3-dimethyl-l-phenyl-5-pyrazolone (nicopyron)]. Med Nov. 1959 Oct 17;42:2003–2005. [PubMed] [Google Scholar]
HART F. D., BURLEY D. Phenylbutazone and its derivatives with special reference to G.27202. Br Med J. 1959 Apr 25;1(5129):1087–1089. doi: 10.1136/bmj.1.5129.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
SCHMIDT W., PAPE J. [Experiences in the treatment of concomitant rheumatic disorders in tuberculotics]. Med Welt. 1961 Sep 23;38:1942–1945. [PubMed] [Google Scholar]

ACTIONS

RESOURCES